Hospital Design and Risk of Nosocomial Infections: A Prospective Controlled Trial

Summary

With the construction of a new medical teaching ward with features designed to reduce hospital-acquired infections, we hypothesized that the design of the new ward was the major factor that contributed to the improved outcomes and designed a prospective, controlled study to examine this hypothesis.

Conditions

• Vancomycin Resistant Enterococci Infection
• Clostridium Difficile Infection
• Nosocomial Infection
• Methicillin Resistant Staphylococcus Aureus Infection (MRSA)

Interventions

OTHER

Admission to a novel hospital ward

Hospital admission to a ward with novel infection control design features (e.g., abundance of sinks, predominance (80%) of private rooms, absence of shared bathrooms, absence of curtains)

Sponsors & Collaborators

• Calgary Health Region

  collaborator OTHER

• Canadian Institutes of Health Research (CIHR)

  collaborator OTHER_GOV

• Alberta Heritage Foundation for Medical Research

  collaborator OTHER

• University of Calgary

  lead OTHER

Principal Investigators

• John M Conly, MD · University of Calgary

• William A Ghali, MD · University of Calgary

• Manuel Mah, MD · Calgary Health Region

• Donna Holton, MD · Calgary Health Region

• Elizabeth A Henderson, PhD · University of Calgary

• Peter Faris, PhD · University of Calgary

• Jean Wallace, PhD · University of Calgary

Study Design

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2007-06-30

Primary Completion

2010-02-28

Completion

2010-02-28

Countries

• Canada

Study Locations